Here's how you can reach us...
  • Tel:
  • Email:

Capillary Zone Electrophoresis-Mass Spectrometry (CZE-MS) Technology

Inquiry

Capillary zone electrophoresis-mass spectrometry (CZE-MS) is an advanced analytical technique that is being applied to the characterization of biopharmaceuticals such as proteins, monoclonal antibodies, vaccines, etc. This technique combines the separation power of CZE with the sensitive detection capability of MS and can be used to identify low concentrations of proteins and their variants, which is often a requirement for biopharmaceutical analysis. CD Formulation integrates cutting-edge CZE-MSE technology into our protein characterization technology platform to provide reliable analytical support for the development and characterization of your protein/peptide drugs to determine drug purity, structural integrity and charge heterogeneity and meet regulatory requirements.

What is Capillary Zone Electrophoresis-Mass Spectrometry (CZE-MS) Technology?

CZE is an analytical chemistry technique that uses an electric field within a thin capillary filled with a buffer solution to separate ionic species based on their charge and size. CZE is characterized by high efficiency, high speed, and low sample and reagent consumption. Compared with liquid chromatography, CZE has extremely low carryover, relatively fast separation speed, and inexpensive instrumentation. CZE, coupled with mass spectrometry, provides a rapid, cost-effective analytical method to help researchers evaluate the quality, consistency, and stability of biopharmaceutical drugs during biopharmaceutical drug development.

Fig. 1 Schematic designs of the CZE-MS systemFig. 1 Schematic designs of the CZE-MS system. (Chen D, et al., 2023)

Capillary Zone Electrophoresis-Mass Spectrometry (CZE-MS) Principle

CZE-MS analysis is based on the separation power of electrophoresis and the sensitive detection capabilities of mass spectrometry. In CZE, an electric field is applied across a narrow capillary filled with an electrolyte solution. Charged proteins migrate through the capillary toward the electrode, and in the presence of the electric field, their migration rate is affected by their charge-to-size ratio (z/e). Smaller and more highly charged molecules migrate faster than larger or less charged molecules. As the analytes migrate, they form distinct zones based on their electrophoretic mobility. This separation occurs rapidly in the small volume of the capillary because of the high electric field strength that can be applied. The analytes exiting the capillary are ionized and analyzed by the mass spectrometer. By detecting the ions, the analytes can be identified and quantified based on their specific mass and abundance.

Our Services Related to CZE-MS

Thanks to decades of experience in supporting protein/peptide biopharmaceutical development and manufacturing using CZE-MS technology, our team of highly qualified experts offers a range of CZE-MS-related services to accelerate the implementation and success of your projects.

Our scientists will work with you to continuously optimize CZE-MS programs to support all stages of protein/peptide drug development and manufacturing - from early protein/peptide drug discovery to late-stage drug development and post-release testing under GMP.

Utilizing cutting-edge CZE-MS technology, we support the following protein/peptide characterization plans, including but not limited to:

Protein Purity Assessment

CZE-MS is an effective tool for assessing the purity of protein drug formulations, with its ability to separate and analyze multiple protein variants simultaneously. Our scientists use this technology to accelerate the development of your project by identifying any impurities and degradation products that may affect drug safety and efficacy during the development and manufacturing of proteins and peptides.

Post-Translational Modifications (PTMs) Characterization

PTMs can occur at every step of the manufacturing process. These modifications can affect the charge state of the molecule and impact the potency of the molecule. As a regulatory release assay, we utilize CZE-MS to identify these charge variants, particularly glycosylation, phosphorylation, and oxidation.

Size Exclusion and Charge Variability Assessment

CZE is able to separate proteins based on their size and charge, providing valuable insights into the heterogeneity of protein drugs. This helps understand the distribution of different protein species in a therapeutic formulation, which is critical to ensuring consistent efficacy and safety.

Protein Quantification

CZE-MS can be used to quantify protein drugs. By calibrating the response of the mass spectrometer, our scientists can determine the concentration of specific protein variants in a complex mixture, enabling precise quantification to support quality control in biopharmaceutical manufacturing.

Biosimilar Comparability Studies

CZE-MS has become an important tool for comparing the structure and function of a reference biologic with its biosimilar. This comparison is critical for regulatory approval and ensuring that biosimilars provide equivalent therapeutic benefits. Our scientists use this tool to help you obtain detailed molecular characteristics of your protein samples, including their charge heterogeneity, molecular weight distribution, and glycosylation patterns, to gain insight into the similarities and differences between the reference biologic and the biosimilar.

Our CZE-MS Equipment

In CZE-MS analysis, the analytes flowing out of CZE need to undergo a certain degree of ionization before entering the mass spectrometer for detection. To this end, our analytical laboratory is equipped with a variety of mass spectrometers with different ionization technologies to meet different analytical needs.

Available Ionization techniques for CZE analysis include:

  • Electrospray ionization (ESI): This technique generates ions from the liquid phase is compatible with CZE. The electric field at the capillary outlet produces a fine mist of charged droplets containing the analyte. This technique is suitable for the analysis of more polar compounds and can achieve high sensitivity and selectivity.
  • Matrix-assisted laser desorption/ionization (MALDI): Although less common in direct capillary systems, it can be used in certain configurations. This technique is more suitable for the analysis of solid samples or high molecular weight substances.

Available MS equipments for CZE analysis include:

  • Quadrupole MS: Quadrupole MS can effectively select and filter ions, and combined with TOF, it can achieve high-resolution and high-sensitivity analysis.
  • Time of Flight (TOF)-MS: TOF-MS can provide high-resolution mass determination, which is particularly suitable for analyzing complex mixtures.
  • Ion Trap-MS: Ion Trap MS can perform multi-stage mass spectrometry analysis and has good analytical capabilities for complex samples.

Advantages of Our CZE-MS Technology

  • High Resolution and Sensitivity: Due to its capillary format, CZE-MS provides excellent resolution, enabling the separation of complex protein mixtures and low-abundance protein molecules with high sensitivity.
  • Rapid Analysis: CZE is inherently faster than traditional gel-based electrophoresis techniques, allowing for shorter sample turnaround and processing times.
  • Minimal Sample Preparation: CZE can reduce the need for extensive sample preparation compared to other separation techniques, helping to maintain the integrity of sensitive analytes.
  • Automated and Reproducible: CZE systems can be highly automated, allowing for reproducible analysis.
  • Ability to Distinguish Modified Forms: CZE-MS is particularly effective in resolving different isoforms of proteins, such as phosphorylation, glycosylation, and methylation.

Custom CZE-MS Services

Residual Host Cell Protein (HCP) Analysis

HCP is a major class of process-related impurities that regulatory agencies require manufacturers to demonstrate have been eliminated during the development of protein/peptide biologics to ensure drug purity, manufacturing process consistency, and patient safety. We use CZE-MS to detect low-level HCP impurities in protein or peptide products to ensure that these products meet specification limits for process residues.

Product-related Impurity Analysis

The isolation and characterization of product-related impurities is an important aspect of process validation and batch-release testing for protein and peptide biopharmaceuticals. In accordance with the ICH Q6B guideline, our impurity analysis team applies a range of highly sensitive analytical techniques such as CZE-MS to characterize and test any possible product-related impurities, including truncations, aggregates, modified forms, and certain degradation products.

Proteins & Peptides Comparability Studies

Comparability studies are key to ensuring that changes in manufacturing processes or formulation conditions don't adversely affect the quality, safety, and efficacy of protein/peptide therapeutic products. We use CZE-MS technology to perform conformational comparability studies of protein/peptide therapeutic products according to the principles of the ICH Q5E guideline.

Proteins & Peptides Biosimilarity Studies

Biosimilarity studies, a key step to ensure the similarity between biosimilars and reference or original drugs, are also important for regulatory agencies to approve biosimilars for marketing. We use CZE-MS technology to perform conformational biosimilarity studies to demonstrate changes in critical quality attributes (CQAs) of protein/peptide biosimilar products, providing highly relevant early characterization and later comparative data.

Why Choose Our CZE-MS Technology?

  • We have a team of experts with rich experience in CZE-MS  analytical method development and validation.
  • We have accumulated decades of expertise and successful project experience using CZE-MS  technology to support protein/peptide biopharmaceutical development.
  • Our CZE-MS technology provides high-resolution separations and accurate mass determination, ensuring that even trace amounts of protein molecules can be reliably detected and quantified.
  • We utilize the latest CZE-MS equipment and methods to provide high-quality results, ensuring your analysis is at the forefront of technology.
  • We provide flexible experimental design and customized solutions.

Publication

Published Data

Technology: CZE-MS/MS for HCP Detection

Journal: Electrophoresis.

IF: 2.744

Published: 2016

Results:

The authors developed a CZE-MS/MS method for the online detection of trace host cell protein impurities in recombinant therapeutics. Synthetic HCP samples were generated by spiking recombinant monoclonal antibodies at five concentration levels of 12 different protein standards, and calibration curves were prepared. After trypsin digestion of the proteins, the spiked protein digests were analyzed using a custom CZE-MS/MS system and ultra-performance liquid chromatography (UPLC)-MS/MS. The results showed that both methods detected all 12 proteins at a spiked level of approximately 100 ppm, but CZE-MS/MS consistently detected more peptides than RPLC-MS/MS for almost all concentrations of the proteins.

Fig. 2 Quantification curves of CZE-MS and RPLC-MS.Fig. 2 Calibration curves for absolute quantification by CZE-MS and RPLC-MS. (Zhu G, et al., 2016)

CD Formulation aims to provide a powerful analytical tool for the separation, purification, and characterization of proteins and peptides. Please feel free to contact us if you are interested in our services. Learn how our CZE-MS technology can support the smooth implementation of your protein/peptide biopharmaceutical program.

References

  1. Chen D, McCool EN, Yang Z, et al. Recent advances (2019-2021) of capillary electrophoresis-mass spectrometry for multilevel proteomics. Mass Spectrom Rev. 2023 Mar;42(2):617-642.
  2. Zhu G, Sun L, Heidbrink-Thompson J, et al. Capillary zone electrophoresis tandem mass spectrometry detects low concentration host cell impurities in monoclonal antibodies. Electrophoresis. 2016 Feb;37(4):616-22.
How It Works
STEP 2
We'll email you to provide your quote and confirm order details if applicable.
STEP 3
Execute the project with real-time communication, and deliver the final report promptly.
Related Services

CD Formulation is an expert in formulation science and pharmaceutical process development in therapeutic proteins & peptides, dedicated to supporting biotherapeutics development and production...

Learn More

  • Tel:
  • Email:

Stay up to date with our latest releases of new research and promotions.

Copyright © CD Formulation. All Rights Reserved.